Suresh K. Mittal

Suresh K. Mittal is a Distinguished Professor of Virology in the Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, IN. He also serves as the Infectious Disease Group Leader for the Purdue Institute of Inflammation, Immunology, and Infectious Disease. He completed his BVSc&AH and MVSc degrees from Haryana Agricultural University, Hisar, Haryana (now named L. L. R. University of Veterinary and Animal Sciences). After completing his PhD degree in molecular virology from the University of Cambridge, Cambridge, U.K., in 1989, Dr. Mittal joined McMaster University in Hamilton, Canada, for his post-doctoral training. Subsequently, in 1992, he joined the Vaccine and Infectious Disease Organization - International Vaccine Center (VIDO-InterVac). He joined Purdue University in 1995 as an Assistant Professor.

Dr. Mittal teaches Veterinary Virology to DVM and graduate students and is also involved in teaching special courses on vaccine design, formulation, and testing. He has trained 12 graduate students, 13 post-doctoral research associates, and several undergraduate and high school students. Dr. Mittal has published over 100 manuscripts or book chapters and has been awarded 8 patents. He has been the recipient of several awards and recognitions for his academic achievements.

He has over 30 years of experience working with adenoviral vectors and is a leader in designing human and nonhuman adenoviral vectors for recombinant vaccines. In the last 20 years, he has acquired excellent expertise in adenoviral vector-based vaccines for seasonal and potential pandemic influenza viruses. Dr. Mittal has ongoing collaborations with Drs. S. Sambhara (CDC), S. Kuchipudi (Penn State), and C. Jagannath (Houston Methodist Research Institute) on the development of vaccines for COVID-19, influenza, and tuberculosis. He also has an ongoing collaboration with the University of São Paulo, Brazil, on evaluating COVID-19 vaccines in animal models. He has been successful in receiving continuous funding from NIAID/NIH for his research program. He serves as an expert for several granting agencies, including the National Institute of Health (NIH), the Centers for Disease Control and Prevention (CDC), the Department of Defense (DoD), and the United States Department of Agriculture (USDA). Overall, Dr. Mittal has extensive expertise in designing novel intervention strategies for emerging and remerging infectious agents.